Outlook Therapeutics (OTLK) Change in Account Payables: 2015-2020
Historic Change in Account Payables for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$2.4 million.
- Outlook Therapeutics' Change in Account Payables fell 495.45% to -$2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$1.5 million, marking a year-over-year decrease of 11.87%. This contributed to the annual value of $1.4 million for FY2024, which is 54.78% down from last year.
- Outlook Therapeutics' Change in Account Payables amounted to -$2.4 million in Q3 2020, which was down 1,756.78% from -$128,706 recorded in Q2 2020.
- Over the past 5 years, Outlook Therapeutics' Change in Account Payables peaked at $5.9 million during Q4 2016, and registered a low of -$7.6 million during Q2 2016.
- Moreover, its 3-year median value for Change in Account Payables was $40,349 (2018), whereas its average is -$235,061.
- Over the last 5 years, Outlook Therapeutics' Change in Account Payables had its largest YoY gain of 2,621.42% in 2016, and its largest YoY loss of 777.19% in 2016.
- Over the past 5 years, Outlook Therapeutics' Change in Account Payables (Quarterly) stood at $5.9 million in 2016, then tumbled by 217.82% to -$6.9 million in 2017, then spiked by 96.25% to -$260,943 in 2018, then surged by 211.20% to $290,178 in 2019, then slumped by 495.45% to -$2.4 million in 2020.
- Its Change in Account Payables stands at -$2.4 million for Q3 2020, versus -$128,706 for Q2 2020 and $738,558 for Q1 2020.